{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T14:05:24Z","timestamp":1704722724048},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T00:00:00Z","timestamp":1508025600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00384-017-2913-6","type":"journal-article","created":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T02:37:31Z","timestamp":1508035051000},"page":"1719-1724","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of early anal cancer: need for guidelines and standardisation"],"prefix":"10.1007","volume":"32","author":[{"given":"Michael P.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarad","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hillman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Grulich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isobel Mary","family":"Poynten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,15]]},"reference":[{"key":"2913_CR1","doi-asserted-by":"publisher","unstructured":"Steele SR, Varma MG, Melton GB et al (2012) Practice parameters for anal squamous neoplasms. Dis Colon rectum 55:735\u2013749. \nhttps:\/\/doi.org\/10.1097\/DCR.0b013e318255815e","DOI":"10.1097\/DCR.0b013e318255815e"},{"key":"2913_CR2","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1200\/JCO.2012.45.2524","volume":"31","author":"RA Nelson","year":"2013","unstructured":"Nelson RA, Levine AM, Bernstein L et al (2013) Changing patterns of anal canal carcinoma in the United States. J Clin Oncol 31:1569\u20131575. \nhttps:\/\/doi.org\/10.1200\/JCO.2012.45.2524","journal-title":"J Clin Oncol"},{"key":"2913_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/jnci\/djs491","volume":"105","author":"A Jemal","year":"2013","unstructured":"Jemal A, Simard EP, Dorell C et al (2013) Annual report to the nation on the status of cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. JNCI Journal of the National Cancer Institute 105:175\u2013201. \nhttps:\/\/doi.org\/10.1093\/jnci\/djs491","journal-title":"JNCI Journal of the National Cancer Institute"},{"key":"2913_CR4","unstructured":"(2017) Australian Institute of Health and Welfare (AIHW) 2017. Australian Cancer Incidence and Mortality (ACIM) books: Anal cancer. Canberra: AIHW. \nhttp:\/\/www.aihw.gov.au\/acim-books\/\n\n. Accessed 14 Jun 2017"},{"key":"2913_CR5","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/ijc.24215","volume":"124","author":"BE Hoots","year":"2009","unstructured":"Hoots BE, Palefsky JM, Pimenta JM, Smith JS (2009) Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 124:2375\u20132383. \nhttps:\/\/doi.org\/10.1002\/ijc.24215","journal-title":"Int J Cancer"},{"key":"2913_CR6","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H Vuyst De","year":"2009","unstructured":"De Vuyst H, Clifford GM, Nascimento MC et al (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 124:1626\u20131636. \nhttps:\/\/doi.org\/10.1002\/ijc.24116","journal-title":"Int J Cancer"},{"key":"2913_CR7","unstructured":"National Comprehensive Cancer Network (2017) Anal Carcinoma Version 2.2017) \nhttps:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/anal.pdf"},{"key":"2913_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.radonc.2013.05.037","volume":"108","author":"AG Bentzen","year":"2013","unstructured":"Bentzen AG, Guren MG, Vonen B et al (2013) Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort. Radiother Oncol 108:55\u201360. \nhttps:\/\/doi.org\/10.1016\/j.radonc.2013.05.037","journal-title":"Radiother Oncol"},{"key":"2913_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/0284186X.2013.770599","volume":"52","author":"AG Bentzen","year":"2012","unstructured":"Bentzen AG, Balteskard L, Wander\u00e5s EH et al (2012) Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol 52:736\u2013744. \nhttps:\/\/doi.org\/10.3109\/0284186X.2013.770599","journal-title":"Acta Oncol"},{"key":"2913_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.radonc.2014.04.013","volume":"111","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones R, Nilsson PJ, Aschele C et al (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol 111:330\u2013339. \nhttps:\/\/doi.org\/10.1016\/j.radonc.2014.04.013","journal-title":"Radiother Oncol"},{"key":"2913_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.clon.2016.10.005","volume":"29","author":"R Muirhead","year":"2017","unstructured":"Muirhead R, Drinkwater K, O'Cathail SM et al (2017) Initial results from the Royal College of Radiologists\u2019 UK National Audit of Anal Cancer Radiotherapy 2015. Clin Oncol 29:188\u2013197. \nhttps:\/\/doi.org\/10.1016\/j.clon.2016.10.005","journal-title":"Clin Oncol"},{"key":"2913_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1463-1318.2010.02494.x","volume":"13","author":"JH Scholefield","year":"2011","unstructured":"Scholefield JH, Harris D, Radcliffe A (2011) Guidelines for management of anal intraepithelial neoplasia. Color Dis 13:3\u201310. \nhttps:\/\/doi.org\/10.1111\/j.1463-1318.2010.02494.x","journal-title":"Color Dis"},{"key":"2913_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/codi.13215","volume":"18","author":"NN Alam","year":"2016","unstructured":"Alam NN, White DA, Narang SK et al (2016) Systematic review of guidelines for the assessment and management of high-grade anal intraepithelial neoplasia (AIN II\/III). Color Dis 18:135\u2013146. \nhttps:\/\/doi.org\/10.1111\/codi.13215","journal-title":"Color Dis"},{"key":"2913_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009244.pub2","volume":"12","author":"A Macaya","year":"2012","unstructured":"Macaya A, Mu\u00f1oz-Santos C, Balaguer A, Barber\u00e0 MJ (2012) Interventions for anal canal intraepithelial neoplasia. Cochrane Database Syst Rev 12:CD009244. \nhttps:\/\/doi.org\/10.1002\/14651858.CD009244.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2913_CR15","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","volume":"83","author":"M Ng","year":"2012","unstructured":"Ng M, Leong T, Chander S et al (2012) Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer. Int J Radiat Oncol Biol Phys 83:1455\u20131462. \nhttps:\/\/doi.org\/10.1016\/j.ijrobp.2011.12.058","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2913_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, Naqa El I et al (2009) Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74:824\u2013830. \nhttps:\/\/doi.org\/10.1016\/j.ijrobp.2008.08.070","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2913_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0895-4356(00)00305-X","volume":"54","author":"DA Braunholtz","year":"2001","unstructured":"Braunholtz DA, Edwards S, Lilford RJ (2001) Are randomized clinical trials good for us (in the short term)? Evidence for a \u201ctrial effect.\u201d. J Clin Epidemiol 54:217\u2013224. \nhttps:\/\/doi.org\/10.1016\/S0895-4356(00)00305-X","journal-title":"J Clin Epidemiol"},{"key":"2913_CR18","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1245\/s10434-015-4391-9","volume":"22","author":"M Jones","year":"2015","unstructured":"Jones M, Hruby G, Solomon M et al (2015) The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis. Ann Surg Oncol 22:3574\u20133581. \nhttps:\/\/doi.org\/10.1245\/s10434-015-4391-9","journal-title":"Ann Surg Oncol"},{"key":"2913_CR19","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/j.prro.2016.01.004","volume":"6","author":"KE Goldman","year":"2016","unstructured":"Goldman KE, White EC, Rao AR et al (2016) Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma. Practical Radiation Oncology 6:e149\u2013e154. \nhttps:\/\/doi.org\/10.1016\/j.prro.2016.01.004","journal-title":"Practical Radiation Oncology"},{"key":"2913_CR20","unstructured":"Edge SB, Byrd DR, Compton CC, et al (2010) AJCC cancer staging manual, 7th edition"},{"key":"2913_CR21","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM200003163421107","volume":"342","author":"DP Ryan","year":"2000","unstructured":"Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342:792\u2013800. \nhttps:\/\/doi.org\/10.1056\/NEJM200003163421107","journal-title":"N Engl J Med"},{"key":"2913_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ejso.2016.02.253","volume":"42","author":"M Alfa-Wali","year":"2016","unstructured":"Alfa-Wali M, Pria AD, Nelson M et al (2016) Surgical excision alone for stage T1 anal verge cancers in people living with HIV. Eur J Surg Oncol 42:813\u2013816. \nhttps:\/\/doi.org\/10.1016\/j.ejso.2016.02.253","journal-title":"Eur J Surg Oncol"},{"key":"2913_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1072-7515(01)00967-X","volume":"185","author":"PR Fuchshuber","year":"1997","unstructured":"Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ (1997) Anal canal and perianal epidermoid cancers. J Am Coll Surg 185:494\u2013505. \nhttps:\/\/doi.org\/10.1016\/S1072-7515(01)00967-X","journal-title":"J Am Coll Surg"},{"key":"2913_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ et al (2013) RTOG 0529: a Phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86:27\u201333. \nhttps:\/\/doi.org\/10.1016\/j.ijrobp.2012.09.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2913_CR25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ijrobp.2017.03.022","volume":"98","author":"KA Goodman","year":"2017","unstructured":"Goodman KA, Julie D, Cercek A, Cambridge L (2017) Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive chemoradiation using intensity modulated. Int J Radiat Oncol Biol Phys 98:1087\u20131095. \nhttps:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2913_CR26","unstructured":"Bell S PLATO: personalising anal cancer radiotherapy dose. \nhttp:\/\/www.isrctn.com\/ISRCTN88455282?q=&filters=conditionCategory:Cancer&sort=&offset=6&totalResults=1847&page=1&pageSize=20&searchType=basic-search\n\n. Accessed 8 May 2017"},{"key":"2913_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S1470-2045(13)70067-6","volume":"14","author":"O Richel","year":"2013","unstructured":"Richel O, de Vries HJC, van Noesel CJM et al (2013) Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. The Lancet Oncology 14:346\u2013353. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(13)70067-6","journal-title":"The Lancet Oncology"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-017-2913-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-017-2913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-017-2913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T03:20:51Z","timestamp":1510802451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-017-2913-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,15]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2913"],"URL":"https:\/\/doi.org\/10.1007\/s00384-017-2913-6","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,15]]}}}